LPCN
#4607
Lipocine Inc. - Common Stock
2.2 1 USD
-0.01%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-0.90%
Monthly Change
+3.76%
6 month change
-76.74%
Year Change
-23.79%
Previous Close
2.2 3
Open
2.2 1
Low
2.2 1
High
2.2 1
Volume
1
Financials
- Market Capitalization 18.22 M
- Employee 14
- Founded 1997
- CEO N/A
- Website www.lipocine.com
- Headquarter Delaware, United States
- FIGI BBG0029L1X69
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-4.75
Price to sales ratio
23.19
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4586 |  LEXX Lexaria Bioscience Corp. - Common Stock | 11.68 USD | +5.80% | +4.10% | +2062.96% | +1212.36% | 19.30 M USD | ||
| 4589 |  RADX Radiopharm Theranostics Limited American Depositary Shares | 2.39 USD | +5.75% | -1.65% | -22.65% | -58.36% | 18.84 M USD | ||
| 4609 |  PTN Palatin Technologies, Inc. Common Stock | 10.26 USD | -2.01% | +1.89% | +28.09% | +41.52% | 18.26 M USD | ||
| 4611 |  CYCN Cyclerion Therapeutics, Inc. - Common Stock | 3.88 USD | -2.76% | -1.52% | +12.14% | +49.23% | 18.16 M USD |
Frequently asked questions about Lipocine Inc.
What is the Lipocine Inc. stock price today?
The current price of Lipocine Inc. (LPCN) is 2.21. Over the past 24 hours, the stock has changed by -0.90%. Follow the LPCN chart for real-time price dynamics.
What is the stock ticker of Lipocine Inc.?
Lipocine Inc. trades under the ticker LPCN. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Lipocine Inc. stock going up?
LPCN has changed by +5.74% over the last week, +3.76% over the last month, and -23.79% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Lipocine Inc.?
Lipocine Inc. currently has a market capitalization of 18.22 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Lipocine Inc. earnings last quarter?
Last quarter, Lipocine Inc. reported earnings of -0.32 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Lipocine Inc. revenue for the last quarter?
Lipocine Inc. reported quarterly revenue of 190.1 K. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Lipocine Inc. net income for the last quarter?
Lipocine Inc. reported net income of -2.62 M for the last quarter. The previous quarter showed -3.67 M, which means net income changed by +28.58%.
How many employees does Lipocine Inc. have?
As of the latest available data, Lipocine Inc. has 14 employees. Workforce size can provide additional context about the company's scale and operations.
What is Lipocine Inc. EBITDA?
Lipocine Inc. EBITDA is -2.91 M, and its EBITDA margin is -1 529.03%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Lipocine Inc. stock?
You can buy Lipocine Inc. (LPCN) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Lipocine Inc. stock?
Investing in Lipocine Inc. requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the LPCN chart and related analysis on metatrader.com as part of your research.